Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes

Plasma suPAR level is predictive of prevalent PAD and of incident cardiovascular and PAD-related events. Whether SuPAR measurement can help screen, risk stratify, or monitor therapeutic responses in PAD requires further investigation.